Investment House LLC continued to hold its stake in shares of Colgate-Palmolive Company (NYSE:CL) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,170 shares of the company’s stock at the end of the first quarter. Investment House LLC’s holdings in Colgate-Palmolive were worth $818,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the company. Blue Chip Partners Inc. boosted its stake in shares of Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after buying an additional 8 shares during the period. Savant Capital LLC boosted its stake in shares of Colgate-Palmolive by 0.3% in the first quarter. Savant Capital LLC now owns 10,526 shares of the company’s stock worth $770,000 after buying an additional 30 shares during the period. Evanson Asset Management LLC boosted its stake in shares of Colgate-Palmolive by 0.3% in the first quarter. Evanson Asset Management LLC now owns 11,869 shares of the company’s stock worth $869,000 after buying an additional 32 shares during the period. Smith Moore & CO. boosted its stake in shares of Colgate-Palmolive by 0.3% in the first quarter. Smith Moore & CO. now owns 10,373 shares of the company’s stock worth $759,000 after buying an additional 32 shares during the period. Finally, Jackson Grant Investment Advisers Inc. boosted its stake in shares of Colgate-Palmolive by 0.5% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 6,993 shares of the company’s stock worth $512,000 after buying an additional 37 shares during the period. 73.15% of the stock is currently owned by institutional investors and hedge funds.

Shares of Colgate-Palmolive Company (NYSE:CL) traded up 0.641% during trading on Thursday, hitting $71.405. The company had a trading volume of 700,257 shares. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The firm’s 50 day moving average is $71.99 and its 200-day moving average is $73.12. The stock has a market capitalization of $62.90 billion, a P/E ratio of 26.535 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. The business had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.70 EPS. Equities research analysts anticipate that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.26%. The ex-dividend date was Friday, July 14th. Colgate-Palmolive’s payout ratio is presently 59.48%.

COPYRIGHT VIOLATION NOTICE: This story was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/colgate-palmolive-company-cl-position-held-by-investment-house-llc/1534127.html.

A number of brokerages recently issued reports on CL. Deutsche Bank AG reissued a “hold” rating and set a $75.00 price objective on shares of Colgate-Palmolive in a report on Monday, July 24th. Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a report on Monday, July 24th. BidaskClub cut Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Jefferies Group LLC increased their price objective on Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a report on Thursday, July 6th. Finally, Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a report on Tuesday, July 4th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $75.82.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $72.41, for a total value of $277,547.53. Following the sale, the insider now owns 53,022 shares of the company’s stock, valued at $3,839,323.02. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Justin Skala sold 74,374 shares of the business’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now directly owns 97,177 shares in the company, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 221,802 shares of company stock worth $15,983,976. Corporate insiders own 1.02% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.